Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alcon Inc
(NY:
ALC
)
79.57
+1.15 (+1.47%)
Official Closing Price
Updated: 7:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Alcon Inc
< Previous
1
2
3
Next >
Alcon Prices US$1.3 Billion Senior Notes Offering
November 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
November 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Third Quarter 2022 Results
November 15, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
October 26, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
September 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
August 23, 2022
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of
Via
Spotlight Growth
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
August 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Second Quarter 2022 Results
August 09, 2022
From
Alcon Inc. Investors
Via
Business Wire
Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday
June 06, 2022
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Prices EUR 500.0 Million Senior Notes Offering
May 24, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
May 23, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports First Quarter 2022 Results
May 10, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Results of 2022 Annual General Meeting
April 27, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries
April 23, 2022
From
Alcon Inc. Corporate
Via
Business Wire
Alcon to Deliver Robust Scientific Program at ASCRS 2022
April 20, 2022
From
Alcon Inc. Investors
Via
Business Wire
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
April 08, 2022
From
Alcon Inc. Corporate
Via
Business Wire
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
April 07, 2022
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Publishes Agenda for 2022 Annual General Meeting
March 24, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Fourth Quarter and Full Year 2021 Results
February 15, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
January 12, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism
January 11, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
January 10, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Third Quarter 2021 Results
November 09, 2021
From
Alcon Inc. Investors
Via
Business Wire
Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021
November 08, 2021
From
Alcon Inc. Corporate
Via
Business Wire
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
November 08, 2021
From
Alcon Inc. Investors
Via
Business Wire
Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs
November 01, 2021
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
October 14, 2021
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Honored with FutureEdge 50 Award
September 27, 2021
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Reports Second Quarter 2021 Results
August 17, 2021
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
August 11, 2021
From
Alcon Inc. Investors
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.